The University of Chicago Header Logo

Connection

Neil Sengupta to Gastrointestinal Agents

This is a "connection" page, showing publications Neil Sengupta has written about Gastrointestinal Agents.
Connection Strength

0.706
  1. Higher vedolizumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease. Scand J Gastroenterol. 2020 Jul; 55(7):800-805.
    View in: PubMed
    Score: 0.659
  2. Association of Antisecretory Drugs with Upper Gastrointestinal Bleeding in Patients Using Oral Anticoagulants: A Systematic Review and Meta-Analysis. Am J Med. 2022 10; 135(10):1231-1243.e8.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.